The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for hum
about
The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer.
P2860
The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for hum
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The European Medicines Agency ...... for medicinal products for hum
@en
The European Medicines Agency ...... for medicinal products for hum
@nl
type
label
The European Medicines Agency ...... for medicinal products for hum
@en
The European Medicines Agency ...... for medicinal products for hum
@nl
prefLabel
The European Medicines Agency ...... for medicinal products for hum
@en
The European Medicines Agency ...... for medicinal products for hum
@nl
P2093
P2860
P1433
P1476
The European Medicines Agency ...... products for human use (CHMP)
@en
P2093
Barbara van Zwieten-Boot
Eric Abadie
Francesco Pignatti
Gonzalo Calvo Rojas
Hadewych Ter Hofstede
Jorge Camarero
Petra Matt
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0224
P407
P577
2011-09-30T00:00:00Z